Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
2075 Results Found
CMS releases FAQs on 2024 Medicare Advantage rule
The Centers for Medicare & Medicaid Services yesterday released FAQs clarifying coverage criteria and utilization management requirements for Medicare Advantage plans under its final rule for calendar year 2024, which includes provisions intended to increase program oversight and create better alignment between MA and Traditional Medicare.
Survey: MA enrollees more likely to report care delays due to prior authorization
People enrolled in Medicare Advantage are more likely than those in traditional Medicare to report delays in care due to needed insurance approvals, according to a survey released Feb. 22 by the Commonwealth Fund, with 13% of traditional Medicare enrollees reporting associated delays compared with 22% of MA enrollees.
CMS seeks sickle cell gene therapy makers to participate in Medicaid drug model
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies for sickle cell disease to apply through May 1 to participate in the Cell and Gene Therapy Access Model.
House passes spending package with certain health care provisions
The House March 6 voted 339-85 to pass a package of six appropriations bills that would fund certain federal agencies through fiscal year 2024 and contains certain health care provisions of interest to hospitals. The Senate is expected to consider the legislation later this week.
Agencies seek input on corporate ownership growth in health care
The Justice Department’s Antitrust Division, Federal Trade Commission and Department of Health and Human Services seek public input through May 6 on increasing private-equity and other corporate ownership in health care, which will inform their future enforcement priorities and efforts to promote competition in health care markets.
Spending package would extend certain health care provisions
The House and Senate Appropriations Committees March 3 released a package of six appropriations bills that would fund certain federal agencies through fiscal year 2024 and contains certain health care provisions of interest to hospitals.
Hospitals testify on proposals to support patients with rare diseases
The House Energy and Commerce Subcommittee on Health Feb. 29 held a hearing on legislative proposals to expand access to treatment for patients with rare diseases, which included two hospital witnesses.
CMS finalizes changes to Medicaid DSH calculation
The Centers for Medicare & Medicaid Services Feb. 20 finalized proposed changes to how states calculate the hospital-specific cap for Medicaid Disproportionate Share Hospitals.
Making our Voice Heard and Leading the Way to Advance Health in America
It is important for us to continue to exercise the principles of democracy that Washington and the Founding Fathers fought so hard for and speak up, asking hard questions of candidates in this election year and evaluating their thinking on the issues that affect our field.
AHA blog: What CMS’ prior authorization final rule means for hospitals, patients
Andrea Preisler, AHA’s senior associate director of administrative simplification policy, explains why the recent final rule requiring Medicare Advantage, Medicaid and federally facilitated Marketplace plans to streamline their prior authorization processes should help reduce the burden on hospitals and clinicians and speed needed care for patients.